- Open Access
A U-shaped relationship between alcohol consumption and cardiometabolic index in middle-aged men
© Wakabayashi. 2016
Received: 15 December 2015
Accepted: 1 March 2016
Published: 9 March 2016
Cardiometabolic index (CMI) is a new index for discriminating diabetes. The purpose of this study was to determine whether CMI is affected by habitual alcohol drinking.
The subjects were 21572 men (35-60 years) receiving annual health checkups. They were divided by average daily ethanol consumption into non-, light (<22 g), moderate (≥22 and < 44 g), heavy (≥44 and < 66 g) and very heavy (≥66 g) drinkers. Relationship between alcohol intake and CMI was investigated with adjustment for age and histories of smoking and regular exercise.
Log-transformed CMI was significantly lower in light, moderate and heavy drinkers than in nondrinkers and was lowest in light drinkers, while there was no significant difference in log-transformed CMI of nondrinkers and very heavy drinkers. Odds ratio vs. nondrinkers for high CMI was significantly lower than the reference level of 1.00 in light, moderate and heavy drinkers and was lowest in light drinkers but was not significantly different from the reference level in very heavy drinkers. Odds ratio of subjects with vs. those without high CMI for hyperglycemia was significantly higher than the reference level in all of the alcohol groups and was significantly lower in moderate drinkers but was not significantly different in the other drinker groups when compared with the nondrinker group.
There is a U-shaped relationship between alcohol consumption and CMI, and moderate drinking but not excessive drinking attenuates the association between CMI and hyperglycemia.
The incidence of cardiovascular disease has been reported to be lower in light-to-moderate drinkers than in abstainers [1, 2]. A major cause of this risk reduction is HDL cholesterol-elevating action of alcohol [3, 4]. Suppression of insulin resistance  and attenuation of blood coagulability through inhibiting platelet aggregation  and decreasing circulating coagulation factors  are also thought to be involved in the alcohol-induced reduction of cardiovascular risk. On the other hand, alcohol drinking is a risk factor of hypertension [8, 9], which is an important etiology of cardiovascular disease . In addition, excessive drinking is associated with an increase of blood triglyceride level [11, 12], and hypertriglyceridemia is a component of metabolic syndrome  and is thought to be a cardiovascular risk factor [14, 15]. Thus, alcohol has both beneficial and harmful effects on the risk of cardiovascular disease, depending on the amount of alcohol consumption.
We have recently proposed cardiometabolic index (CMI) as a new lipid- and adiposity-related index that is strongly associated with prevalence of diabetes . CMI is calculated as the product of waist-to-height ratio and triglycerides-to-HDL cholesterol ratio and has been shown to be associated with progression of atherosclerosis in patients with peripheral arterial disease (PAD) . Diabetes is an important risk factor of PAD, and an inverse association has been shown between light-to-moderate alcohol consumption and the risk of PAD . However, it is unknown whether and how CMI is affected by alcohol drinking. Light-to-moderate drinking has been shown to be inversely associated with insulin resistance, and the incidence of diabetes has been reported to be lower in light-to-moderate drinkers than in nondrinkers [5, 19, 20]. Thus, it is also of interest to know whether the association between CMI and diabetes is modified by alcohol drinking.
The purpose of this concise study was therefore to determine the relationship between alcohol drinking and CMI in a large population of middle-aged Japanese men and to compare the strength of the association between CMI and hyperglycemia among subject groups with different amounts of alcohol consumption.
The subjects were Japanese men aged 35 - 60 years (n = 21572) who had received periodic health checkup examinations at workplaces in Yamagata Prefecture in Japan. This study was approved by the Ethics Committee of Yamagata University School of Medicine (No. 112 from April 2005 to March 2006, approved on March 13, 2006). Histories of alcohol consumption, cigarette smoking, regular exercise (almost every day with exercise for 30 min or longer per day) and illness were surveyed by questionnaires. Those who had been receiving drug therapy for dyslipidemia (4.7 %) were excluded from the subjects of this study. The subjects were divided into four groups by average cigarette consumption (nonsmokers; light smokers, < 20 cigarettes per day; heavy smokers, ≥ 20 and < 40 cigarettes per day; very heavy smokers, ≥ 40 cigarettes per day).
Evaluation of alcohol consumption
Average alcohol consumption of each subject per week was reported on questionnaires. Frequency of habitual alcohol drinking was asked in the questionnaire as “How frequently do you drink alcohol?”. Frequency of weekly alcohol drinking was categorized as “every day” (regular drinkers), “sometimes” (occasional drinkers) and “never” (nondrinkers). Only regular drinkers who answered “every day” were used as drinkers for analysis in this study, since it was difficult to know the correct average alcohol consumption of occasional drinkers who answered “sometimes”. Occasional drinkers were thus excluded from subjects for analysis, and regular drinkers were compared with nondrinkers in this study. Usual weekly alcohol consumption was recorded in terms of the equivalent number of “go”, a traditional Japanese unit of amount of sake (rice wine). The amounts of other alcoholic beverages, including beer, wine, whisky and shochu (traditional Japanese distilled spirit), were converted and expressed as units of “go”. One “go” contains about 22 g of ethanol, and this amount was used to separate moderate-to-heavy drinkers from light drinkers since it is generally accepted that alcohol intake should be reduced to less than 20 – 30 g ethanol per day from the viewpoint of prevention of hypertension [21, 22]. Average daily alcohol intake (grams of ethanol per day) was then calculated. The subjects were divided into five groups according to ethanol consumption per day (non-drinkers; light drinkers: < 22 g of ethanol per day; moderate drinkers: ≥ 22 and < 44 g of ethanol per day; heavy drinkers, ≥ 44 and < 66 g of ethanol per day; very heavy drinkers: ≥ 66 g ethanol per day).
Waist circumference was measured at the navel level according to the recommendation of the definition of the Japanese Committee for the Diagnostic Criteria of Metabolic Syndrome . Fasted blood was sampled from each subject, and serum triglycerides and HDL cholesterol were measured by enzymatic methods using commercial kits, pureauto S TG-N and cholestest N-HDL (Sekisui Medical Co., Ltd, Tokyo, Japan), respectively. CMI was calculated as the product of waist-to-height ratio and triglycerides-to-HDL cholesterol ratio, and high CMI was defined as CMI ≥ 1.625, which has been reported to discriminate hyperglycemia best in men . Blood hemoglobin A1c, which reflects glucose tolerance status more correctly than does blood glucose, was used for evaluation of hyperglycemia. Hemoglobin A1c was determined by the latex cohesion method using a commercial kit (Determiner HbA1c, Kyowa Medex, Tokyo, Japan). Coefficients of variation for reproducibility of each measurement were ≤ 3 % for triglycerides and ≤ 5 % for HDL cholesterol and hemoglobin A1c. Hemoglobin A1c values were calibrated by using a formula proposed by the Japan Diabetes Society (JDS) as hemoglobin A1c (National Glycohemoglobin Standardization Program) (%) = 1.02 x hemoglobin A1c (JDS) (%) + 0.25 % . Hyperglycemia including diabetes and prediabetes was defined as hemoglobin A1c ≥ 5.7 % according to the criteria of the American Diabetes Association . Subjects receiving drug therapy for diabetes were included in the hyperglycemia group.
Statistical analyses were performed using a computer software program (SPSS version 16.0 J for Windows, Chicago IL, USA). Mean levels of each quantitative variable were compared using analysis of variance (ANOVA) followed by Scheffé’s F-test in univariate analysis and analysis of covariance (ANCOVA) followed by Student’s t-test after Bonferroni correction in multivariate analysis. Since triglycerides and CMI did not show a normal distribution, they were compared non-parametrically by using the Kruskal-Wallis test followed by the Steel-Dwass test in univariate analysis or were used after logarithmic transformation in ANCOVA. Comparison of percentages of each categorical variable between groups was performed using the chi-square test for independence. In logistic regression analysis, odds ratios for high CMI or hyperglycemia were estimated. Age and histories of smoking and habitual exercise were used as other explanatory variables in multivariate analyses. In multivariate analyses, smoking and exercise were defined categorically as history of smoking in 4 levels (non, light, heavy and very heavy smokers) and history of habitual exercise in 2 levels (with and without history), respectively. Age was used as a quantitative explanatory variable. Crude odds ratios were compared between different alcohol groups by using the Breslow-Day test. Probability (p) values less than 0.05 were defined as significant.
Characteristics of the subjects
Characteristics of subjects
48.3 ± 7.5
47.0 ± 7.7
47.9 ± 7.6**
48.8 ± 7.4**
49.4 ± 7.2**
47.6 ± 7.3
Habitual exercise (%)
Therapy for diabetes (%)
169.3 ± 6.2
169.1 ± 6.4
169.3 ± 6.1
169. 3 ± 6.0
169. 5 ± 6.0*
170. 1 ± 6.2**
Waist circumference (cm)
83.3 ± 8.7
83.5 ± 10.0
82.5 ± 8.1**
83.1 ± 8.1*
83.6 ± 8.1
84.2 ± 8.7
0.492 ± 0.051
0.494 ± 0.058
0.487 ± 0.048**
0.491 ± 0.047**
0.493 ± 0.047
0.495 ± 0.049
118 (78, 185)
116 (79, 178)
109 (73, 164)**
118 (77, 184)
130 (80, 208)**
144 (88, 236)**
HDL cholesterol (mg/dl)
57.5 ± 15.4
50.8 ± 12.6
57.5 ± 14.2**
60.1 ± 15.6**
61.9 ± 16.0**
63.2 ± 16.6**
1.05 (0.59, 1.89)
1.16 (0.67, 2.07)
0.95 (0.55, 1.65)**
0.99 (0.56, 1.76)**
1.06 (0.57, 2.01)**
1.15 (0.64, 2.18)
1.60 ± 1.98
1.66 ± 1.65
1.38 ± 1.54
1.52 ± 1.91
1.77 ± 2.68
1.80 ± 1.98
High CMI (%)
Hemoglobin A1c (%)
5.50 ± 0.72
5.61 ± 0.86
5.48 ± 0.69**
5.45 ± 0.61**
5.46 ± 0.71**
5.43 ± 0.67**
Comparison of CMI and each component of CMI among the alcohol groups
Odds ratios vs. nondrinkers for high CMI in each drinker group
Odds ratios for high cardiometabolic index (CMI) of each drinker group vs. the nondrinker group
Very heavy drinkers
Relationships of alcohol intake with hemoglobin A1c and hyperglycemia
Hemoglobin A1c and the percentage of subjects with hyperglycemia were significantly lower in light, moderate, heavy and very heavy drinkers than in nondrinkers (Table 1). In ANCOVA with adjustment for age and histories of smoking, regular exercise and medication therapy for diabetes, hemoglobin A1c was also significantly lower (p < 0.01) in light, moderate, heavy and very heavy drinkers than in nondrinkers (means with standard errors: 5.60 ± 0.01 % [nondrinkers] vs. 5.49 ± 0.01 % [light drinkers] vs. 5.45 ± 0.01 % [moderate drinkers] vs. 5.45 ± 0.01 % [heavy drinkers] vs. 5.46 ± 0.03 % [very heavy drinkers]).
Odds ratios of subjects with vs. those without high CMI for hyperglycemia in each drinker group
Odds ratios for hyperglycemia of subjects with vs. subjects without high cardiometabolic index (CMI)
Very heavy drinkers
2.31 (2.05-2.60) *
OR of interaction term
Comparison of the CMI-related variables in non- and very heavy drinkers matched for height
Comparison of cardiometabolic index (CMI)-related variables between height-matched non- and very heavy drinker groups
Very heavy drinkers
170.05 ± 0.24
170.10 ± 0.24
1.15 (0.67, 2.15)
1.15 (0.64, 2.18)
0.095 ± 0.014
0.065 ± 0.014
High CMI (%)
OR for high CMI
This study is the first study showing the relationship between alcohol drinking and CMI, a recently proposed index that is strongly associated with prevalence of diabetes . There was a U-shaped relationship between alcohol consumption and CMI (Fig. 1, Table 2). These relationships were independent of smoking and regular exercise in ANCOVA and multivariate logistic regression analysis, although smoking and physical activity are known to affect blood lipids and adiposity [26, 27]. All CMI-related variables tested showed no significant differences in nondrinkers and very heavy drinkers matched for height. Thus, the difference in height between nondrinkers and very heavy drinkers (Table 1) did not confound the relationship between CMI and very heavy drinking. CMI has been shown to be related to progression of atherosclerosis in carotid artery and ischemia in leg artery of patients with peripheral arterial disease . The finding of lower CMI in light and moderate drinkers than in nondrinkers in the present study agrees with the known lower risk of cardiovascular disease in light-to-moderate drinkers than in nondrinkers [1, 2]. Thus, modest alcohol drinking is inversely associated with prevalence of cardiovascular disease. On the other hand, no significant association was found between CMI and very heavy drinking. Excessive drinking is known to show adverse effects on cardiovascular health . In addition, alcohol is related not only to cardiovascular disease but also to various other diseases including cancer, and there is a possibility of alcohol abuse in drinkers. Therefore, needless to say, even modest drinking should not be recommended.
The odds ratio of subjects with vs. those without high CMI for hyperglycemia was significantly higher than the reference level in non-, light, moderate, heavy and very heavy drinkers. Thus, CMI was positively associated with hyperglycemia in all of the alcohol groups. The odds ratio for hyperglycemia was significantly lower only in moderate drinkers than in nondrinkers, and the interaction term of alcohol (each drinker group vs. nondrinkers) and CMI (high vs. not high CMI) for hyperglycemia was significantly lower than the reference level only in moderate drinkers. These results imply that the association between CMI and hyperglycemia was significantly weaker in moderate drinkers than in nondrinkers but was not significantly different in the other drinker groups and nondrinkers. Thus, moderate drinking is inversely associated with CMI, and the association between cardiometabolic risk and diabetes is weaker in moderate drinkers than in nondrinkers. The findings of this study suggest that alcohol intake should be taken into account when CMI is used as an index related to the risk of atherosclerotic disease and diabetes.
CMI is calculated by WHtR, an adiposity index, and triglycerides-to-HDL cholesterol ratio, a lipid index. Lower WHtR and higher HDL cholesterol resulted in lower CMI in light and moderate drinkers than in nondrinkers, while comparable CMI levels in nondrinkers and very heavy drinkers may be due to higher triglycerides and higher HDL cholesterol in very heavy drinkers than in nondrinkers. Lower triglycerides also contributed to lower CMI in light drinkers than in nondrinkers. CMI in heavy drinkers was significantly lower than that in nondrinkers, and both HDL cholesterol and triglycerides in heavy drinkers were higher than those in nondrinkers. These results may imply that the influence of higher HDL cholesterol on CMI is stronger than the influence of higher triglycerides on CMI in heavy drinkers.
There are limitations of this study. Age and histories of smoking and regular exercise were adjusted in multivariate analyses in this study. However, there are other factors, e.g., diet, nutrition and socioeconomic factors including education and occupation, possibly confounding the relationship between alcohol consumption and the components of CMI, such as adiposity and blood lipids, and information on these possible confounders was not available in this study. In addition, symptoms caused by alcohol drinking, such as facial flushing and palpitation, that are often found in Asians are mainly explained by increase in blood acetoaldehyde level and are known to be strongly influenced by polymorphism of genes of alcohol-metabolizing enzymes, especially acetoaldehyde dehydrogenase 2 (ALDH2) [29, 30]. Polymorphism of the cholesteryl ester transfer protein (CETP) gene has been shown to modify the relationship between alcohol consumption and the risk of coronary artery disease [31, 32]. However, information on the polymorphism of these proteins was not included in the database used in the present study. The subjects of this study were Japanese men, and further studies are needed to determine the relationship between alcohol and CMI in women and individuals of other races and/or ethnicities. This study is cross-sectional in its design, and further prospective studies are also needed to clarify causality of the relationship between alcohol drinking and CMI.
In conclusion, there was a U-shaped relationship between alcohol consumption and CMI, and the positive association between CMI and hyperglycemia was weaker in moderate drinkers but was not different in the other drinker groups when compared with nondrinkers. Thus, CMI and its relation to hyperglycemia are different in drinkers and nondrinkers depending on the amount of alcohol intake, and status of habitual drinking should be taken into account when CMI is used as an index related to the risk of atherosclerotic disease and diabetes.
This work was supported by a Grant-in-Aid for Scientific Research (No. 24390171) from the Japan Society for the Promotion of Science.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000;95:1505–23.View ArticlePubMedGoogle Scholar
- Reynolds K, Lewis LB, Nolen JDL, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579–88.View ArticlePubMedGoogle Scholar
- Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol. 2002;37:409–15.View ArticlePubMedGoogle Scholar
- Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J. 1999;319(7224):1523–8.View ArticleGoogle Scholar
- Hulthe J, Fagerberg B. Alcohol consumption and insulin sensitivity: a review. Metab Syndr Relat Disord. 2005;3:45–50.View ArticlePubMedGoogle Scholar
- Rubin R, Rand ML. Alcohol and platelet function. Alcohol Clin Exp Res. 1994;18:105–10.View ArticlePubMedGoogle Scholar
- Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb. 1992;12:780–8.View ArticlePubMedGoogle Scholar
- Klatsky AL. Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension: does it matter? Yes. J Cardiovasc Risk. 2003;10:21–4.View ArticlePubMedGoogle Scholar
- Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–90.View ArticlePubMedGoogle Scholar
- James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.View ArticlePubMedGoogle Scholar
- Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet. 1977;2:153–5.View ArticlePubMedGoogle Scholar
- Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 1992;85:910–5.View ArticlePubMedGoogle Scholar
- Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366:1059–62.View ArticlePubMedGoogle Scholar
- Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–9.View ArticlePubMedGoogle Scholar
- Labreuche J, Touboul PJ, Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. Atherosclerosis. 2009;203:331–45.View ArticlePubMedGoogle Scholar
- Wakabayashi I, Daimon T. The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274–8.View ArticlePubMedGoogle Scholar
- Wakabayashi I, Sotoda Y, Hirooka S, Orita H. Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease. Clin Chim Acta. (in press).Google Scholar
- Sotoda Y, Wakabayashi I. Peripheral arterial disease. In: Wakabayashi I, Groschner K, editors. Interdisciplinary concepts in cardiovascular health, vol. III: Springer, Switzerland; 2014. p. 115–45. doi:10.1007/978-3-319-01074-8.
- Carlsson S, Hammar N, Grill V. Alcohol consumption and type 2 diabetes Meta-analysis of epidemiological studies indicates a U-shaped relationship. Diabetologia. 2005;48:1051–4.View ArticlePubMedGoogle Scholar
- Koppes LL, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719–25.View ArticlePubMedGoogle Scholar
- Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. Japanese Society of Hypertension committee. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res. 2009;32:3–107.View ArticlePubMedGoogle Scholar
- Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.View ArticlePubMedGoogle Scholar
- Anonymous. Metabolic Syndrome-definition and diagnostic criteria in Japan. J Japan Soc Int Med. 2005;94:794–809. in Japanese.View ArticleGoogle Scholar
- Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society (JDS). International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. Diabetol Int. 2012;3:8–10.View ArticleGoogle Scholar
- Anonymous. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62–9.Google Scholar
- Gastaldelli A, Folli F, Maffei S. Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk. Curr Pharm Des. 2010;16:2526–30.View ArticlePubMedGoogle Scholar
- Koba S, Tanaka H, Maruyama C, Tada N, Birou S, Teramoto T, et al. Physical activity in the Japan population: association with blood lipid levels and effects in reducing cardiovascular and all-cause mortality. J Atheroscler Thromb. 2011;18:833–45.View ArticlePubMedGoogle Scholar
- Lucas DL, Brown RA, Wassef M, Giles TD. Alcohol and the cardiovascular system: research challenges and opportunities. J Am Coll Cardiol. 2005;45:1916–24.View ArticlePubMedGoogle Scholar
- Mizoi Y, Tatsuno Y, Adachi J, Kogame M, Fukunaga T, Fujiwara S, Hishida S, Ijiri I. Alcohol sensitivity related to polymorphism of alcohol-metabolizing enzymes in Japanese. Pharmacol Biochem Behav. 1983;18 Suppl 1:127–33.View ArticlePubMedGoogle Scholar
- Suddendorf RF. Research on alcohol metabolism among Asians and its implications for understanding causes of alcoholism. Public Health Rep. 1989;104:615–20.PubMedPubMed CentralGoogle Scholar
- Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 1995;96:1664–71.View ArticlePubMedPubMed CentralGoogle Scholar
- Jensen MK, Mukamal KJ, Overvad K, Rimm EB. Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. Eur Heart J. 2008;29:104–12.View ArticlePubMedGoogle Scholar